| scholarly article | Q13442814 |
| P356 | DOI | 10.1038/MT.2010.298 |
| P8608 | Fatcat ID | release_oomomfquyjf5hnnrrlyw3mqm4q |
| P932 | PMC publication ID | 3070099 |
| P698 | PubMed publication ID | 21224833 |
| P5875 | ResearchGate publication ID | 49745663 |
| P50 | author | Michael D. Mühlebach | Q60981009 |
| Andreas Plückthun | Q23057697 | ||
| P2093 | author name string | Christian Jost | |
| Klaus Cichutek | |||
| Christian J Buchholz | |||
| Robert C Münch | |||
| Thomas Schaser | |||
| Sabrina Kneissl | |||
| P2860 | cites work | Importance of the cytoplasmic tails of the measles virus glycoproteins for fusogenic activity and the generation of recombinant measles viruses | Q39684160 |
| Targeting trastuzumab-resistant breast cancer cells with a lentivirus engineered to bind antibodies that recognize HER-2. | Q39727268 | ||
| Specific gene transfer to neurons, endothelial cells and hematopoietic progenitors with lentiviral vectors | Q42863043 | ||
| An oncolytic measles virus engineered to enter cells through the CD20 antigen | Q45729228 | ||
| High-level transduction and gene expression in hematopoietic repopulating cells using a human immunodeficiency [correction of imunodeficiency] virus type 1-based lentiviral vector containing an internal spleen focus forming virus promoter | Q45732758 | ||
| Lentiviral vector retargeting to P-glycoprotein on metastatic melanoma through intravenous injection | Q46167187 | ||
| Removal of the conserved disulfide bridges from the scfv fragment of an antibody: effects on folding kinetics and aggregation | Q57840042 | ||
| Designed to be stable: crystal structure of a consensus ankyrin repeat protein | Q24550750 | ||
| A designed ankyrin repeat protein evolved to picomolar affinity to Her2 | Q27644627 | ||
| High-affinity binders selected from designed ankyrin repeat protein libraries | Q28257550 | ||
| Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo | Q29616612 | ||
| The ankyrin repeat: a diversity of interactions on a common structural framework | Q29616794 | ||
| Targeting human T cells by retroviral vectors displaying antibody domains selected from a phage display library | Q30840200 | ||
| The scFv fragment of the antibody hu4D5-8: evidence for early premature domain interaction in refolding | Q31853054 | ||
| Efficient selection of DARPins with sub-nanomolar affinities using SRP phage display | Q33360541 | ||
| Redirecting lentiviral vectors by insertion of integrin-tageting peptides into envelope proteins. | Q33711459 | ||
| A versatile targeting system with lentiviral vectors bearing the biotin-adaptor peptide. | Q33711477 | ||
| Her2-specific multivalent adapters confer designed tropism to adenovirus for gene targeting | Q33740415 | ||
| Receptors and entry cofactors for retroviruses include single and multiple transmembrane-spanning proteins as well as newly described glycophosphatidylinositol-anchored and secreted proteins. | Q34010373 | ||
| Biology of HER2 and its importance in breast cancer | Q34428745 | ||
| The oncogene HER2: its signaling and transforming functions and its role in human cancer pathogenesis | Q34493341 | ||
| Medicine. A comeback for gene therapy | Q34613525 | ||
| DARPins: a true alternative to antibodies. | Q34653885 | ||
| Gene delivery by lentivirus vectors | Q34688367 | ||
| Cell entry by measles virus: long hybrid receptors uncouple binding from membrane fusion | Q35861422 | ||
| Affinity thresholds for membrane fusion triggering by viral glycoproteins | Q36315685 | ||
| Measles virus: cellular receptors, tropism and pathogenesis | Q36590422 | ||
| Strategies for targeting lentiviral vectors | Q37347165 | ||
| Lentiviral vectors with measles virus glycoproteins - dream team for gene transfer? | Q37425507 | ||
| Novel anticancer targets: revisiting ERBB2 and discovering ERBB3. | Q37523202 | ||
| Targeted cell entry of lentiviral vectors | Q37589994 | ||
| P433 | issue | 4 | |
| P304 | page(s) | 686-693 | |
| P577 | publication date | 2011-01-11 | |
| P1433 | published in | Molecular Therapy | Q15762400 |
| P1476 | title | DARPins: an efficient targeting domain for lentiviral vectors | |
| P478 | volume | 19 |
| Q30378994 | A Highly Immunogenic and Protective Middle East Respiratory Syndrome Coronavirus Vaccine Based on a Recombinant Measles Virus Vaccine Platform. |
| Q57839812 | A Library-Based Screening Strategy for the Identification of DARPins as Ligands for Receptor-Targeted AAV and Lentiviral Vectors |
| Q38917869 | A scalable method to concentrate lentiviral vectors pseudotyped with measles virus glycoproteins |
| Q59356321 | A simple strategy for retargeting lentiviral vectors to desired cell types via a disulfide-bond-forming protein-peptide pair |
| Q34163977 | Antiviral activity of recombinant ankyrin targeted to the capsid domain of HIV-1 Gag polyprotein |
| Q41899254 | CD105 is a surface marker for receptor-targeted gene transfer into human long-term repopulating hematopoietic stem cells |
| Q35238704 | CD133-targeted gene transfer into long-term repopulating hematopoietic stem cells |
| Q42254939 | CD19 and CD20 targeted vectors induce minimal activation of resting B lymphocytes |
| Q60948710 | CD46 Null Packaging Cell Line Improves Measles Lentiviral Vector Production and Gene Delivery to Hematopoietic Stem and Progenitor Cells |
| Q41877997 | Cell type specific gene delivery by lentiviral vectors: New options in immunotherapy |
| Q39199726 | DARPin-targeting of measles virus: unique bispecificity, effective oncolysis, and enhanced safety |
| Q45943585 | Designed Ankyrin Repeat Proteins as Her2 Targeting Domains in Chimeric Antigen Receptor-Engineered T Cells. |
| Q42541148 | Displaying high-affinity ligands on adeno-associated viral vectors enables tumor cell-specific and safe gene transfer |
| Q36777139 | Enhanced lysis by bispecific oncolytic measles viruses simultaneously using HER2/neu or EpCAM as target receptors |
| Q40562689 | In Vivo Gene Delivery to Lymph Node Stromal Cells Leads to Transgene-specific CD8+ T Cell Anergy in Mice. |
| Q41643722 | In vitro incorporation of a cell-binding protein to a lentiviral vector using an engineered split intein enables targeted delivery of genetic cargo |
| Q34447329 | Measles virus glycoprotein-based lentiviral targeting vectors that avoid neutralizing antibodies |
| Q36607409 | Nipah virus envelope-pseudotyped lentiviruses efficiently target ephrinB2-positive stem cell populations in vitro and bypass the liver sink when administered in vivo |
| Q38709200 | Non-integrating gamma-retroviral vectors as a versatile tool for transient zinc-finger nuclease delivery |
| Q41493938 | Off-target-free gene delivery by affinity-purified receptor-targeted viral vectors |
| Q27013679 | Pros and Cons of Antigen-Presenting Cell Targeted Tumor Vaccines |
| Q36047074 | Receptor-Targeted Nipah Virus Glycoproteins Improve Cell-Type Selective Gene Delivery and Reveal a Preference for Membrane-Proximal Cell Attachment |
| Q38906090 | Receptor-targeted lentiviral vectors are exceptionally sensitive toward the biophysical properties of the displayed single-chain Fv. |
| Q26861563 | Recombinant messenger RNA technology and its application in cancer immunotherapy, transcript replacement therapies, pluripotent stem cell induction, and beyond |
| Q45875762 | Retargeting Lentiviruses via SpyCatcher-SpyTag Chemistry for Gene Delivery into Specific Cell Types |
| Q37358531 | Specific targeting of human interleukin (IL)-13 receptor α2-positive cells with lentiviral vectors displaying IL-13. |
| Q39347239 | Sstr2A: a relevant target for the delivery of genes into human glioblastoma cells using fiber-modified adenoviral vectors |
| Q92948927 | Studies of the oligomerisation mechanism of a cystatin-based engineered protein scaffold |
| Q38825120 | Surface modification via strain-promoted click reaction facilitates targeted lentiviral transduction |
| Q58726929 | Surface-Engineered Lentiviral Vectors for Selective Gene Transfer into Subtypes of Lymphocytes |
| Q35666025 | Targeted entry via somatostatin receptors using a novel modified retrovirus glycoprotein that delivers genes at levels comparable to those of wild-type viral glycoproteins |
| Q45876186 | Targeted lentiviral vectors pseudotyped with the Tupaia paramyxovirus glycoproteins |
| Q64084185 | The Effects of Pertuzumab and Its Combination with Trastuzumab on HER2 Homodimerization and Phosphorylation |
| Q55183005 | The effects of trastuzumab on HER2-mediated cell signaling in CHO cells expressing human HER2. |
| Q36827199 | The receptor attachment function of measles virus hemagglutinin can be replaced with an autonomous protein that binds Her2/neu while maintaining its fusion-helper function |
| Q46300096 | Ultraviolet phototoxicity of upconversion nanoparticles illuminated with near-infrared light. |
| Q90444691 | Vectofusin-1 Improves Transduction of Primary Human Cells with Diverse Retroviral and Lentiviral Pseudotypes, Enabling Robust, Automated Closed-System Manufacturing |
| Q36757162 | Vectofusin-1, a new viral entry enhancer, strongly promotes lentiviral transduction of human hematopoietic stem cells. |
| Q57050793 | Versatile targeting system for lentiviral vectors involving biotinylated targeting molecules |
Search more.